LexDanaLexDanabeta
Inventor

Colette Song

Inventor
Ostfildern, DE

Overview

83→
Patents
2018–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 83 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C07KPeptides16%
C12NMicroorganisms or enzymes16%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms10%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology6%
C12YEnzymes5%
G06FElectric digital data processing2%
G16CComputational chemistry2%
PatentTitleYear
10,870,685Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods202010,869,917A*03 restricted peptides for use in immunotherapy against cancers and related methods202010,842,817Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers202010,836,806Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers202010,835,586Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers202010,829,537Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers202010,828,357A*03 restricted peptides for use in immunotherapy against cancers and related methods202010,800,823Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers202010,793,602Immunotherapy against several tumors, such as lung cancer, including NSCLC202010,780,125Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers202010,765,730Peptides and combination of peptides for use in immunotherapy against various cancers202010,722,536Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers202010,711,048Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers202010,703,795Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers202010,688,131Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers202010,669,325Uterine cancer treatments202010,668,100Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers202010,662,233Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers202010,626,162Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers202010,597,434Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers202010,596,196Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers202010,577,402Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers202010,550,167Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers202010,548,958Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers202010,525,084Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers202010,525,116Peptides and combination of peptides for use in immunotherapy against various cancers202010,526,389Peptides and combinations of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers202010,487,132Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers201910,487,116Immunotherapy against several tumors, such as lung cancer, including NSCLC201910,479,818Immunotherapy against several tumors, such as lung cancer, including NSCLC201910,478,481Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers201910,472,402Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers201910,449,240Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers201910,450,357Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers201910,434,159Peptides and combination of peptides for use in immunotherapy against various cancers201910,435,449Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers201910,400,011Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers201910,392,427Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers201910,383,896Peptides and combination of peptides for use in immunotherapy against various cancers201910,385,105Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers201910,376,542Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers201910,377,803Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers201910,364,282Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers201910,363,296Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers201910,357,552Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers201910,342,859Peptides and combination of peptides for use in immunotherapy against various cancers201910,323,065Immunotherapy against several tumors, such as lung cancer, including NSCLC201910,316,063Immunotherapy against several tumors, such as lung cancer, including NSCLC201910,314,897Peptides and combination of peptides for use in immunotherapy against various cancers201910,314,896Peptides and combination of peptides for use in immunotherapy against various cancers201910,316,062Immunotherapy against several tumors, such as lung cancer, including NSCLC201910,314,899Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers201910,294,288Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers201910,279,022Peptides and combination of peptides for use in immunotherapy against various cancers201910,273,282Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers201910,272,114Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers201910,266,581Uterine cancer treatments201910,238,691Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers201910,239,930Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers201910,239,932Uterine cancer treatments201910,221,229Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers201910,214,577Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers201910,213,498Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers201910,202,437Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers201910,195,232Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers201910,189,886Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers201910,179,165Peptides and combination of peptides for use in immunotherapy against various cancers201910,167,331Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers201910,160,786Immunotherapy against several tumors, such as lung cancer, including NSCLC201810,143,730Peptides and combination of peptides for use in immunotherapy against various cancers201810,143,731Peptides and combination of peptides for use in immunotherapy against various cancers201810,138,287Uterine cancer treatments201810,117,917Peptides and combination of peptides for use in immunotherapy against various cancers201810,105,428Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers201810,098,937Peptides and combination of peptides for use in immunotherapy against various cancers201810,098,938Peptides and combination of peptides for use in immunotherapy against various cancers201810,071,148Immunotherapy against several tumors, such as lung cancer, including NSCLC201810,058,598Peptides and combination of peptides for use in immunotherapy against various cancers201810,011,645Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers201810,004,792Peptides and combination of peptides for use in immunotherapy against various cancers20189,993,536Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers20189,943,579Immunotherapy against several tumors, such as lung cancer, including NSCLC20189,931,388Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers2018

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2018–2020Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (83)· patent assignee history
2018–2020Based in Ostfildern, DE· patent location history
2019Patents assigned to INMATICS BIOTECHNOLOGIES GMBH (3)· patent assignee history
2019Patents assigned to IMMAICS BIOTECHNOLOGIES GMBH (1)· patent assignee history
2019Based in Ostifildern, DE· patent location history
2019Based in Otsfildern, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
IMMATICS BIOTECHNOLOGIES GMBH832018–2020
INMATICS BIOTECHNOLOGIES GMBH32019
IMMAICS BIOTECHNOLOGIES GMBH12019
Locations
LocationPatentsSpan
Ostfildern, DE812018–2020
Ostifildern, DE12019
Otsfildern, DE12019